Article PDF
Avoid common mistakes on your manuscript.
References
Abbracchio MP, Burnstock G (1994) Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64: 445-475
Anderson CM, Parkinson FE (1997) Potential signalling roles for UTP and UDP: sources, regulation and release of uracil nucleotides. Trends Pharmacol Sci 18:387-392
Barnard EA, Simon J, Webb TE (1997) Nucleotide receptors in the nervous system: an abundant component using diverse transduction mechanisms. Mol Neurobiol 15:103-129
Deckert J, Gleiter CH (1994) Adenosine - an endogenous neuroprotective metabolite and neuromodulator. J Neural Transm [Suppl] 43:23-31
Deussen A (2000) Metabolic flux rates of adenosine in the heart. Naunyn-Schmiedeberg’s Arch Pharmacol (this issue). DOI 10.1007/s002100000318
Di Virgilio F, Sanz JM, Chiozzi P, Falzoni S (1999) The P2Z/P2X7 receptor of microglial cells: a novel immunomodulatory receptor. Prog Brain Res 120:356-368
Drury AN, Szent-Györgyi A (1929) The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 68:213-237
Dubyak GR, El-Moatassim C (1993) Signal transduction via P2- purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 34:C577-C606
Engler RL, Gruber HE (1992) Adenosine: an autacoid. In: Fozzard HA, Haber E, Jennings R, Katz A, Morgan H (eds) The heart and cardiovascular system, 2nd edn. Raven, New York, pp 1745-1764
Fabre J-E, Nguyen MT, Latour A, Keifer JA, Audoly LP, Coffman TM, Koller BH (1999) Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 5:1199-1202
Feoktistov I, Polosa R, Holgate ST, Biaggioni I (1998) Adenosine A2B receptors: a novel therapeutic target in asthma? Trends Pharmacol Sci 19:148-153
Filippov AK, Webb TE, Barnard EA, Brown DA (1998) P2Y2 nucleotide receptors expressed heterologously in sympathetic neurons inhibit both N-type Ca2+ and M-type K+ currents. J Neurosci 18:5170-5179
Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51: 83-133
Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wassermann W (2000) Structure and function of adenosine receptors and their genes. Naunyn-Schmiedeberg’s Arch Pharmacol (this issue). DOI 10.1007/s002100000313
Guthrie PB, Knappenberger J, Segal M, Bennett MVL, Charles AC, Kater SB (1999) ATP release from astrocytes mediates glial calcium waves. J Neurosci 19:520-528
Haas HL, Selbach O (2000) Functions of neuronal adenosine receptors. Naunyn-Schmiedeberg’s Arch Pharmacol (this issue). DOI 10.1007/s002100000314
Jacobson KA, Kim HO, Siddiqi SM, Olah ME, Stiles GL, Lubitz DKJE von (1995) A3-adenosine receptors: design of selective ligands and therapeutic prospects. Drugs Future 20:689-699
Klotz K-N (2000) Adenosine receptors and their ligands. Naunyn- Schmiedeberg’s Arch Pharmacol (this issue). DOI 10.1007/ s002100000315
Klotz K-N, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ (1998) Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg’s Arch Pharmacol 357:1-9
Kügelgen I von, Starke K (1991) Noradrenaline-ATP co-transmission in the sympathetic nervous system. Trends Pharmacol Sci 12:319-324
Kügelgen I von, Wetter A (2000) Molecular pharmacology of P2Y-receptors. Naunyn-Schmiedeberg’s Arch Pharmacol (this issue). DOI 10.1007/s002100000310
Lambrecht G (2000) Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications.
Naunyn-Schmiedeberg’s Arch Pharmacol (this issue). DOI 10.1007/s002100000312
MacKenzie AB, Surprenant A, North RA (1999) Functional and molecular diversity of purinergic ion channel receptors. Ann NY Acad Sci 868:716-729
Müller CE, Stein B (1996) Adenosine receptor antagonists: structure and potential therapeutic applications. Curr Pharm Des 2: 501-530
Mulryan K, Gitterman DP, Lewis CJ, Vial C, Leckle BJ, Cobb AL, Brown JE, Conley EC, Buell G, Pritchard CA, Evans RJ (2000) Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 403:86-89
Neary JT, Rathbone MP, Cattabeni F, Abbracchio MP, Burnstock G (1996) Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci 19:13-Nörenberg W, Illes P (2000) Neuronal P2X receptors: localisation and functional properties. Naunyn-Schmiedeberg’s Arch Pharmacol (this issue). DOI 10.1007/s002100000311
Olsson RA, Pearson JD (1990) Cardiovascular purinoceptors. Physiol Rev 70:761-845
Poulsen S-A, Quinn RJ (1998) Adenosine receptors: new opportunities for future drugs. Bioorg Med Chem 6:619-641
Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492
Richardson PJ, Kase H, Jenner PG (1997) Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson’s disease. Trends Pharmacol Sci 18:338-344
Sugita M, Yue Y, Foskett JK (1998) CFTR Cl-channel and CFTRassociated ATP channel: distinct pores regulated by common gates. EMBO J 17:898-908
Vulchanova L, Riedl MS, Shuster SJ, Stone LS, Hargreaves KM, Buell G, Surprenant A, North RA, Elde R (1998) P2X3 is expressed by DG neurons that terminate in inner lamina II. Eur J Neurosci 10:3470-3478
Zimmermann H (2000) Extracellular hydrolysis of ATP and other nucleotides. Naunyn-Schmiedeberg’s Arch Pharmacol (this issue). DOI 10.1007/s002100000309
Zimmermann H, Braun N (1999) Ecto-nucleotidases - molecular structures, catalytic properties, and functional roles in the nervous system. Prog Brain Res 120:371-385
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Illes, P., Klotz, KN. & Lohse, M.J. Signaling by extracellular nucleotides and nucleosides. Naunyn-Schmied Arch Pharmacol 362, 295–298 (2000). https://doi.org/10.1007/s002100000308
Published:
Issue Date:
DOI: https://doi.org/10.1007/s002100000308